Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Current Deferred Revenue (2018 - 2026)

AdaptHealth has reported Current Deferred Revenue over the past 8 years, most recently at $59.8 million for Q4 2025.

  • For Q4 2025, Current Deferred Revenue rose 71.25% year-over-year to $59.8 million; the TTM value through Dec 2025 reached $59.8 million, up 71.25%, while the annual FY2025 figure was $59.8 million, 71.25% up from the prior year.
  • Current Deferred Revenue for Q4 2025 was $59.8 million at AdaptHealth, roughly flat from $59.9 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $59.9 million in Q3 2025 and troughed at $22.3 million in Q3 2021.
  • A 5-year average of $37.3 million and a median of $34.4 million in 2023 define the central range for Current Deferred Revenue.
  • Biggest five-year swings in Current Deferred Revenue: skyrocketed 184.07% in 2021 and later decreased 25.3% in 2024.
  • Year by year, Current Deferred Revenue stood at $31.4 million in 2021, then increased by 0.86% to $31.6 million in 2022, then grew by 21.9% to $38.6 million in 2023, then decreased by 9.4% to $34.9 million in 2024, then soared by 71.25% to $59.8 million in 2025.
  • Business Quant data shows Current Deferred Revenue for AHCO at $59.8 million in Q4 2025, $59.9 million in Q3 2025, and $56.3 million in Q2 2025.